Restrictive cardiomyopathy due to storage disease (Q96351): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Cardiomiopatia restritiva devido à doença de depósito é a presença de cardiomiopatia restritiva na presença de um glicogênio, esfingolipidoses (como deficiência de α-galactosidase-A (doença de Anderson-Fabry)), mucopolissacaridoses (como deficiência de α-l iduronidase (síndrome de Hurler)), sobrecarga de ferro (como hemocromatose) ou outro transtorno de depósito conhecido por estar significativamente associado à cardiomiopatia restritiva. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Restrictive cardiomyopathy due to storage disease is the presence of restrictive cardiomyopathy in the presence of a glycogen, sphingolipidoses (such as α-galactosidase-A deficiency (Anderson-Fabry disease)), mucopolysaccharidoses (such as α-l iduronidase deficiency (Hurler syndrome)), iron-overload (such as haemochromatosis), or other storage disorder known to be significantly associated with restrictive cardiomyopathy. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1721344709 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_1721344709 | |||||||||||||||
| Property / CURIE: CID11:ID_1721344709 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_1721344709 | |||||||||||||||
| Property / Canary Token: dki-india-ID_1721344709 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 12:19, 16 August 2026
Restrictive cardiomyopathy due to storage disease is the presence of restrictive cardiomyopathy in the presence of a glycogen, sphingolipidoses (such as α-galactosidase-A deficiency (Anderson-Fabry disease)), mucopolysaccharidoses (such as α-l iduronidase deficiency (Hurler syndrome)), iron-overload (such as haemochromatosis), or other storage disorder known to be significantly associated with restrictive cardiomyopathy.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1721344709 |
||
| English | Restrictive cardiomyopathy due to storage disease |
Restrictive cardiomyopathy due to storage disease is the presence of restrictive cardiomyopathy in the presence of a glycogen, sphingolipidoses (such as α-galactosidase-A deficiency (Anderson-Fabry disease)), mucopolysaccharidoses (such as α-l iduronidase deficiency (Hurler syndrome)), iron-overload (such as haemochromatosis), or other storage disorder known to be significantly associated with restrictive cardiomyopathy. |
Statements
CID11:ID_1721344709
0 references
dki-india-ID_1721344709
0 references
Concluído
0 references
15 August 2026
0 references
